Literature DB >> 24755847

Curcumin treatment attenuates pain and enhances functional recovery after incision.

Peyman Sahbaie1, Yuan Sun, De-Yong Liang, Xiao-You Shi, J David Clark.   

Abstract

BACKGROUND: Acute pain after surgery remains moderate to severe for 20% to 30% of patients despite advancements in the use of opioids, adjuvant drugs, and regional anesthesia. Depending on the type of surgery, 10% to 50% of patients experience persistent pain postoperatively, and there are no established methods for its prevention. Curcumin (diferuloylmethane) is one of the phenolic constituents of turmeric that has been used in Eastern traditional medicine as an antiseptic, antioxidant, anti-inflammatory, and analgesic agent. It may be effective for treating postoperative pain.
METHODS: We used the hindpaw incision model with C57BL/6 mice. Sensitization to mechanical and thermal stimuli as well as effects on edema and temperature were measured up to 7 days after surgery. Spontaneous pain after incision was assessed by using conditioned place preference (CPP), and alterations in gait function were assessed using multiparameter digital gait analysis.
RESULTS: Curcumin (50 mg/kg) significantly reduced the intensity of mechanical and heat sensitization after hindpaw incision in mice. No effects of curcumin on baseline nociceptive thresholds were observed. Curcumin also reduced hindpaw swelling after incision, suggesting an anti-inflammatory effect. In addition, perioperative curcumin treatment attenuated hyperalgesic priming due to incision when mice were subsequently challenged with hindpaw prostaglandin E2 application. Furthermore, while vehicle-treated mice had evidence of spontaneous pain 48 hours after incision in the CPP paradigm, no evidence of ongoing pain was observed in the mice treated with curcumin. Likewise, hindpaw incision caused changes in several gait-related indices, but most of these were normalized in the curcumin-treated animals. The peri-incisional levels of several pronociceptive immune mediators including interleukin (IL)-1β, IL-6, tumor necrosis factor α, and macrophage inflammatory protein-1α were either not reduced or were even augmented 1 and 3 days after incision in curcumin-treated mice. The anti-inflammatory cytokine IL-10 was unchanged, while transforming growth factor-β levels were enhanced under the same conditions.
CONCLUSIONS: Our studies suggest that curcumin treatment is effective in alleviating incision-induced inflammation, nociceptive sensitization, spontaneous pain, and functional gait abnormalities. Augmented transforming growth factor-β production provides one possible mechanism. These preclinical findings demonstrate curcumin's potential as a preventative strategy in postoperative pain treatment.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24755847     DOI: 10.1213/ANE.0000000000000189

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  16 in total

1.  Optogenetic Inhibition of CGRPα Sensory Neurons Reveals Their Distinct Roles in Neuropathic and Incisional Pain.

Authors:  Ashley M Cowie; Francie Moehring; Crystal O'Hara; Cheryl L Stucky
Journal:  J Neurosci       Date:  2018-06-20       Impact factor: 6.167

Review 2.  Targeting AMPK for the Alleviation of Pathological Pain.

Authors:  Marina N Asiedu; Gregory Dussor; Theodore J Price
Journal:  Exp Suppl       Date:  2016

3.  Sex differences in a Murine Model of Complex Regional Pain Syndrome.

Authors:  Maral Tajerian; Peyman Sahbaie; Yuan Sun; David Leu; Hsun Yu Yang; Wenwu Li; Ting Ting Huang; Wade Kingery; J David Clark
Journal:  Neurobiol Learn Mem       Date:  2015-06-09       Impact factor: 2.877

4.  Pre-treatment with microRNA-181a Antagomir Prevents Loss of Parvalbumin Expression and Preserves Novel Object Recognition Following Mild Traumatic Brain Injury.

Authors:  Brian B Griffiths; Peyman Sahbaie; Anand Rao; Oiva Arvola; Lijun Xu; Deyong Liang; Yibing Ouyang; David J Clark; Rona G Giffard; Creed M Stary
Journal:  Neuromolecular Med       Date:  2019-03-21       Impact factor: 3.843

Review 5.  Adenosine Monophosphate-activated Protein Kinase (AMPK) Activators For the Prevention, Treatment and Potential Reversal of Pathological Pain.

Authors:  Theodore J Price; Vaskar Das; Gregory Dussor
Journal:  Curr Drug Targets       Date:  2016       Impact factor: 3.465

6.  Pharmacological validation of voluntary gait and mechanical sensitivity assays associated with inflammatory and neuropathic pain in mice.

Authors:  Andrew J Shepherd; Durga P Mohapatra
Journal:  Neuropharmacology       Date:  2017-11-27       Impact factor: 5.250

7.  Antinociceptive Effect of the Citrus Flavonoid Eriocitrinon Postoperative Pain Conditions.

Authors:  Saad Alghamdi
Journal:  J Pain Res       Date:  2020-04-22       Impact factor: 3.133

Review 8.  Effects of Curcumin and Its Different Formulations in Preclinical and Clinical Studies of Peripheral Neuropathic and Postoperative Pain: A Comprehensive Review.

Authors:  Paramita Basu; Camelia Maier; Arpita Basu
Journal:  Int J Mol Sci       Date:  2021-04-28       Impact factor: 5.923

9.  Autonomic Regulation of Nociceptive and Immunologic Changes in a Mouse Model of Complex Regional Pain Syndrome.

Authors:  Peyman Sahbaie; Wen-Wu Li; Tian-Zhi Guo; Xiao-You Shi; Wade S Kingery; J David Clark
Journal:  J Pain       Date:  2021-10-23       Impact factor: 5.820

10.  Antinociceptive effects of vitexin in a mouse model of postoperative pain.

Authors:  Qing Zhu; Li-Na Mao; Cheng-Peng Liu; Yue-Hua Sun; Bo Jiang; Wei Zhang; Jun-Xu Li
Journal:  Sci Rep       Date:  2016-01-14       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.